March 25, 2022
Addressing common misconceptions can help avoid misconstrued scientific facts
January 25, 2022
Timing is key in reducing the risk of developing vision loss or blindness.
January 13, 2022
ASCENT, RegenXBio’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.
January 10, 2022
Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye!
January 03, 2022
January 02, 2022
Exciting news from OYE Technology!
November 12, 2021
Diabetic papillitis is relatively rare, found in type 1 and 2 diabetes patients
October 27, 2021
October 04, 2021
Remain vigilant to recurrences to apply potential treatments
September 15, 2021
Practitioners spend more time diagnosing glaucoma or diabetic retinopathy than AMD
Eyeglasses target myopia prevention with artificial light
Research to Prevent Blindness, Aerie partner on glaucoma research grant
Character Biosciences raises $18 million in funding for AMD therapy development
COVID-19: Increased incidence of RVOs post-diagnosis
